AGNC

Business Context and Reporting Period

Company: AGNC Investment Corp.
Filing Type: Form 8-K (Current Report)
Reporting Date: November 19, 2018 (Event Date: November 14, 2018)
Context: The Company entered into a material definitive agreement to conduct a public offering of common stock.

Key Financial Metrics and Transaction Details

This filing reports a capital raise transaction rather than periodic financial performance metrics (revenue, profit, cash flow). Key transaction figures include:

• Initial Shares Sold: 40,000,000 shares of common stock.
• Option Shares: Underwriters granted an option to purchase up to 6,000,000 additional shares.
• Total Potential Shares: 46,000,000 shares.
• Closing Date: November 19, 2018.
• Option Exercise: Underwriters exercised the full option on November 19, 2018.
• Underwriters: Credit Suisse, Citigroup, J.P. Morgan, Morgan Stanley, Goldman Sachs, and Merrill Lynch.

Note: The filing text does not provide the offering price per share, total gross proceeds, or net proceeds after underwriting discounts.

Material Changes Versus Prior Period

This 8-K filing does not report comparative financial performance against a prior period. The material change is the execution of the Underwriting Agreement and the subsequent increase in the Company's outstanding share count due to the sale of Initial Shares and the exercise of the Option.

Guidance, Outlook, and Risks

Management Commentary: The filing confirms the sale was made pursuant to an effective shelf registration statement (Form S-3, File No. 333-225628).
Risks and Contingencies:

• The Underwriting Agreement includes customary representations, warranties, and covenants.
• The Company provided customary indemnification for losses arising from the sale of the Shares.
• Underwriters and their affiliates may engage in various financing and advisory services with the Company for which they receive customary fees.

Important Facts for Investor Verification

• Verify the specific offering price per share and total gross proceeds in the associated Prospectus Supplement (not included in this 8-K text).
• Confirm the dilution impact of the 46,000,000 new shares on existing shareholders.
• Review the full Underwriting Agreement (Exhibit 1.1) for specific lock-up periods or other covenants.
• Check subsequent filings for the use of proceeds from this capital raise.